Proceedings

Diversity-Aware Reinforcement Learning for de novo Drug Design

Download BibTeX Cite

Proceedings of the Thirty-Fourth International Joint Conference on Artificial Intelligence. AI4Tech: AI Enabling Technologies. Pages 9194-9204.

https://doi.org/10.24963/ijcai.2025/1022

Abstract

Fine-tuning a pre-trained generative model has demonstrated good performance in generating promising drug molecules. The fine-tuning task is often formulated as a reinforcement learning problem, where previous methods efficiently learn to optimize a reward function to generate potential drug molecules. Nevertheless, in the absence of an adaptive update mechanism for the reward function, the optimization process can become stuck in local optima. The efficacy of the optimal molecule in a local optimization may not translate to usefulness in the subsequent drug optimization process or as a potential standalone clinical candidate. Therefore, it is important to generate a diverse set of promising molecules. Prior work has modified the reward function by penalizing structurally similar molecules, primarily focusing on finding molecules with higher rewards. To date, no study has comprehensively examined how different adaptive update mechanisms for the reward function influence the diversity of generated molecules. In this work, we investigate a wide range of intrinsic motivation methods and strategies to penalize the extrinsic reward, and how they affect the diversity of the set of generated molecules. Our experiments reveal that combining structure- and prediction-based methods generally yields better results in terms of diversity.

  1. [Atance et al., 2022] Sara Romeo Atance, Juan Viguera Diez, Ola Engkvist, Simon Olsson, and Rocío Mercado. De novo drug design using reinforcement learning with graph-based deep generative models. Journal of chemical information and modeling, 62(20):4863-4872, 2022.
  2. [Badia et al., 2020] Adrià Puigdomènech Badia, Pablo Sprechmann, Alex Vitvitskyi, Daniel Guo, Bilal Piot, Steven Kapturowski, Olivier Tieleman, Martín Arjovsky, Alexander Pritzel, Andew Bolt, and Charles Blundell. Never give up: Learning directed exploration strategies, 2020.
  3. [Bellemare et al., 2016] Marc G. Bellemare, Sriram Srini- vasan, Georg Ostrovski, Tom Schaul, David Saxton, and Rémi Munos. Unifying count-based exploration and in- trinsic motivation. In Daniel D. Lee, Masashi Sugiyama, Ulrike von Luxburg, Isabelle Guyon, and Roman Garnett, editors, Advances in Neural Information Processing Sys- tems 29: Annual Conference on Neural Information Pro- cessing Systems 2016, December 5-10, 2016, Barcelona, Spain, pages 1471-1479, 2016.
  4. [Bemis and Murcko, 1996] Guy W Bemis and Mark A Mur- cko. The properties of known drugs. 1. molecular frame- works. Journal of medicinal chemistry, 39(15):2887- 2893, 1996.
  5. [Blaschke et al., 2020a] Thomas Blaschke, Josep Arús- Pous, Hongming Chen, Christian Margreitter, Christian Tyrchan, Ola Engkvist, Kostas Papadopoulos, and Atanas Patronov. Reinvent 2.0: an ai tool for de novo drug design. Journal of chemical information and modeling, 60(12):5918-5922, 2020.
  6. [Blaschke et al., 2020b] Thomas Blaschke, Ola Engkvist, Jürgen Bajorath, and Hongming Chen. Memory-assisted reinforcement learning for diverse molecular de novo de- sign. Journal of cheminformatics, 12(1):68, 2020.
  7. [Burda et al., 2018] Yuri Burda, Harrison Edwards, Amos Storkey, and Oleg Klimov. Exploration by random net- work distillation. arXiv preprint arXiv:1810.12894, 2018.
  8. [DiMasi et al., 2016] Joseph A DiMasi, Henry G Grabowski, and Ronald W Hansen. Innovation in the pharmaceutical industry: new estimates of r&d costs. Journal of health economics, 47:20-33, 2016.
  9. [Gao et al., 2022] Wenhao Gao, Tianfan Fu, Jimeng Sun, and Connor W. Coley. Sample efficiency matters: A benchmark for practical molecular optimization. In Sanmi Koyejo, S. Mohamed, A. Agarwal, Danielle Belgrave, K. Cho, and A. Oh, editors, Advances in Neural Informa- tion Processing Systems 35: Annual Conference on Neu- ral Information Processing Systems 2022, NeurIPS 2022, New Orleans, LA, USA, November 28 -December 9, 2022, 2022.
  10. [Garivier and Cappé, 2011] Aurélien Garivier and Olivier Cappé. The kl-ucb algorithm for bounded stochastic ban- dits and beyond. In Sham M. Kakade and Ulrike von Luxburg, editors, Proceedings of the 24th Annual Con- ference on Learning Theory, volume 19 of Proceedings of Machine Learning Research, pages 359-376, Budapest, Hungary, 09-11 Jun 2011. PMLR.
  11. [Gaulton et al., 2017] Anna Gaulton, Anne Hersey, Michał Nowotka, A Patricia Bento, Jon Chambers, David Mendez, Prudence Mutowo, Francis Atkinson, Louisa J Bellis, Elena Cibrián-Uhalte, et al. The chembl database in 2017. Nucleic acids research, 45(D1):D945-D954, 2017.
  12. [Gummesson Svensson et al., 2024] Hampus Gummes- son Svensson, Christian Tyrchan, Ola Engkvist, and Morteza Haghir Chehreghani. Utilizing reinforcement learning for de novo drug design. Machine Learning, 113(7):4811-4843, 2024.
  13. [Guo and Schwaller, 2024] Jeff Guo and Philippe Schwaller. Augmented memory: Sample-efficient generative molecu- lar design with reinforcement learning. Jacs Au, 2024.
  14. [Hochreiter, 1997] S Hochreiter. Long short-term memory. Neural Computation MIT-Press, 1997.
  15. [Huang et al., 2021] Kexin Huang, Tianfan Fu, Wenhao Gao, Yue Zhao, Yusuf Roohani, Jure Leskovec, Con- nor W Coley, Cao Xiao, Jimeng Sun, and Marinka Zitnik. Therapeutics data commons: Machine learning datasets and tasks for drug discovery and development. Proceed- ings of Neural Information Processing Systems, NeurIPS Datasets and Benchmarks, 2021.
  16. [Huang et al., 2022] Kexin Huang, Tianfan Fu, Wenhao Gao, Yue Zhao, Yusuf Roohani, Jure Leskovec, Connor W Coley, Cao Xiao, Jimeng Sun, and Marinka Zitnik. Artifi- cial intelligence foundation for therapeutic science. Nature Chemical Biology, 2022.
  17. [Hughes et al., 2011] James P Hughes, Stephen Rees, S Bar- rett Kalindjian, and Karen L Philpott. Principles of early drug discovery. British journal of pharmacology, 162(6):1239-1249, 2011.
  18. [Jaccard, 1912] Paul Jaccard. The distribution of the flora in the alpine zone. 1. New phytologist, 11(2):37-50, 1912.
  19. [Jasial et al., 2016] S Jasial, Y Hu, M Vogt, and J Bajo- rath. Activity-relevant similarity values for fingerprints and implications for similarity searching. F1000Research, 5(591), 2016.
  20. [Landrum, 2006] Greg Landrum. Rdkit: Open-source chem- informatics. http://www.rdkit.org, 2006. Link
  21. [Laud, 2004] Adam Daniel Laud. Theory and application of reward shaping in reinforcement learning. PhD thesis, University of Illinois at Urbana-Champaign, 2004.
  22. [Liu et al., 2021] Xuhan Liu, Kai Ye, Herman WT van Vli- jmen, Michael TM Emmerich, Adriaan P IJzerman, and Gerard JP van Westen. Drugex v2: de novo design of drug molecules by pareto-based multi-objective reinforcement learning in polypharmacology. Journal of cheminformat- ics, 13(1):85, 2021.
  23. [Loeffler et al., 2024] Hannes H Loeffler, Jiazhen He, Alessandro Tibo, Jon Paul Janet, Alexey Voronov, Lewis H Mervin, and Ola Engkvist. Reinvent 4: Modern ai-driven generative molecule design. Journal of Cheminformatics, 16(1):20, 2024.
  24. [Olivecrona et al., 2017] Marcus Olivecrona, Thomas Blaschke, Ola Engkvist, and Hongming Chen. Molecular de-novo design through deep reinforcement learning. Journal of cheminformatics, 9:1-14, 2017.
  25. [Park et al., 2025] Jinyeong Park, Jaegyoon Ahn, Jonghwan Choi, and Jibum Kim. Mol-air: Molecular reinforcement learning with adaptive intrinsic rewards for goal-directed molecular generation. Journal of Chemical Information and Modeling, 65(5):2283-2296, 2025.
  26. [Pitt et al., 2025] Will R. Pitt, Jonathan Bentley, Christophe Boldron, Lionel Colliandre, Carmen Esposito, Eliza- beth H. Frush, Jola Kopec, Stéphanie Labouille, Jerome Meneyrol, David A. Pardoe, Ferruccio Palazzesi, Al- fonso Pozzan, Jacob M. Remington, René Rex, Michelle Southey, Sachin Vishwakarma, and Paul Walker. Real- world applications and experiences of ai/ml deployment for drug discovery. Journal of Medicinal Chemistry, 2025. PMID: 39772505.
  27. [Popova et al., 2018] Mariya Popova, Olexandr Isayev, and Alexander Tropsha. Deep reinforcement learning for de novo drug design. Science advances, 4(7):eaap7885, 2018.
  28. [Quancard et al., 2023] Jean Quancard, Anna Vulpetti, An- ders Bach, Brian Cox, Stéphanie M Guéret, Ingo V Har- tung, Hannes F Koolman, Stefan Laufer, Josef Messinger, Gianluca Sbardella, et al. The european federation for medicinal chemistry and chemical biology (efmc) best practice initiative: Hit generation. ChemMedChem, 18(9):e202300002, 2023.
  29. [Renz et al., 2019] Philipp Renz, Dries Van Rompaey, Jörg Kurt Wegner, Sepp Hochreiter, and Günter Klam- bauer. On failure modes in molecule generation and op- timization. Drug Discovery Today: Technologies, 32:55- 63, 2019.
  30. [Renz et al., 2024] Philipp Renz, Sohvi Luukkonen, and Guünter Klambauer. Diverse hits in de novo molecule design: Diversity-based comparison of goal-directed gen- erators. Journal of Chemical Information and Modeling, 64(15):5756-5761, 2024.
  31. [Reymond, 2015] Jean-Louis Reymond. The chemical space project. Accounts of chemical research, 48(3):722-730, 2015.
  32. [Rogers and Hahn, 2010] David Rogers and Mathew Hahn. Extended-connectivity fingerprints. Journal of chemical information and modeling, 50(5):742-754, 2010.
  33. [Segler et al., 2018] Marwin HS Segler, Thierry Kogej, Christian Tyrchan, and Mark P Waller. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS central science, 4(1):120-131, 2018.
  34. [Sun et al., 2017] Jiangming Sun, Nina Jeliazkova, Vladimir Chupakhin, Jose-Felipe Golib-Dzib, Ola Engkvist, Lars Carlsson, Jörg Wegner, Hugo Ceulemans, Ivan Georgiev, Vedrin Jeliazkov, et al. Excape-db: an integrated large scale dataset facilitating big data analysis in chemoge- nomics. Journal of cheminformatics, 9:1-9, 2017.
  35. [Thomas et al., 2022a] Morgan Thomas, Noel M. O'Boyle, Andreas Bender, and Chris De Graaf. Re-evaluating sam- ple efficiency in de novo molecule generation, 2022.
  36. [Thomas et al., 2022b] Morgan Thomas, Noel M O'Boyle, Andreas Bender, and Chris De Graaf. Augmented hill-climb increases reinforcement learning efficiency for language-based de novo molecule generation. Journal of cheminformatics, 14(1):68, 2022.
  37. [Velez-Arce et al., 2024] Alejandro Velez-Arce, Xiang Lin, Kexin Huang, Michelle M Li, Wenhao Gao, Bradley Pen- telute, Tianfan Fu, Manolis Kellis, and Marinka Zitnik. Signals in the cells: Multimodal and contextualized ma- chine learning foundations for therapeutics. In NeurIPS 2024 Workshop on AI for New Drug Modalities, 2024.
  38. [Wang and Zhu, 2024] Jing Wang and Fei Zhu. Exselfrl: An exploration-inspired self-supervised reinforcement learn- ing approach to molecular generation. Expert Systems with Applications, page 125410, 2024.
  39. [Weininger, 1988] David Weininger. Smiles, a chemical lan- guage and information system. 1. introduction to method- ology and encoding rules. Journal of chemical information and computer sciences, 28(1):31-36, 1988.
  40. [Wouters et al., 2020] Olivier J Wouters, Martin McKee, and Jeroen Luyten. Estimated research and development in- vestment needed to bring a new medicine to market, 2009- 2018. JAMA, 323(9):844-853, 2020.
  41. [Xie et al., 2023] Yutong Xie, Ziqiao Xu, Jiaqi Ma, and Qiaozhu Mei. How much space has been explored? measuring the chemical space covered by databases and machine-generated molecules. In 11th International Con- ference on Learning Representations (ICLR 2023). Inter- national Conference on Learning Representations (ICLR), 2023.

References were extracted automatically from the PDF and may contain errors.

Welcome Future Conferences AI Journal Division IJCAI Proceedings About IJCAI IJCAI Awards